Breaking News

Bora Pharmaceuticals to Scale Supply of Oncology Therapy

Groninger FlexPro 50 Isolator Line provides U.S.-based fill/finish capacity for partners in oncology and specialty drug manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. has partnered with Accord BioPharma to manufacture pre-filled syringes of UDENYCA (pegfilgrastim-cbqv), a product recently added to Accord’s portfolio. Leveraging its Groninger FlexPro 50 Isolator Line for vials and pre-filled syringes at its Baltimore site Bora will help scale supply of a vital therapy to support immune health in cancer care. Bora combines its CDMO expertise in aseptic fill/finish capabilities for vials and pre-filled syringes with the latest i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters